• Eczema
  • COPD Move
  • CRD Closing banner
  • Banner Child

    Putting you at the centre of all decisions affecting your health

  • Banner map

    30% of the European population lives with allergies, asthma and COPD

  • Banner hands

    Because breathing is taken for granted, we work for better recognition of chronic respiratory diseases

Search Library
EFA launches #ShowLeadership campaign
Living with allergies and airways diseases has become a daily burden for over 200 million people in Europe. The drastic increase of people living with allergy, asthma and COPD has overwhelmed the Euro ...

Read more

WHO urges stronger action to reduce deaths from Non-Communicable diseases in Europe
On April 9th and 10th, the World Health Organisation (WHO) held a High-Level Conference on Non Communicable Diseases (NCDs) in Turkmenistan. The discussions were focused on national actions to reduce  ...

Read more

Delivering patient value discussed at EU Parliament
To mark the 13th European Patients’ Rights Day, EFA attended the conference on ‘Delivering patient value throughout the healthcare system’ organised in the European Parliament by the Active Citizenshi ...

Read more

EU Coalition for Vaccination unites for confidence
The first meeting of the ‘EU Coalition for Vaccination’, convened by the European Commission Directorate General on Health and Food Safety (DG SANTE) united student and healthcare professional organis ...

Read more

Save the Date: FENAER’s first online congress for respiratory patients
EFA Spanish Member Federacion Española de Asociaciones de pacientes alergicos y con Enfermedades Respiratorias (FENAER) will hold its first online Congress next 8th of June. The Satellite event for pe ...

Read more

Allergy and respiratory patients present a European campaign calling for action for better care and prevention
On March 20th, the European Parliament Interest Group on Allergy and Asthma organised the last policy meeting of the current mandate, aimed at renewing the EU policy agenda on allergy and airways dise ...

Read more

EFA patient leaders make our Annual General Meeting 2019 in Brussels a success
On March 19th and 20th EFA celebrated the Annual General Meeting (AGM) of Members in Brussels, Belgium and launched the EFA annual report 2018, Shedding Light into the Severity of Allergy and Airways  ...

Read more

European Parliament Interest Group on Allergy and Asthma launches a Blueprint
On 20th March, the European Parliament Interest Group on Allergy and Asthma, co-run by EFA and EAACI, organised at the European Parliament a Breakfast Policy Meeting on a renewed EU policy agenda on a ...

Read more

First guidance on new rules for certain medical devices by European Medical Agency
The European Medicines Agency (EMA) has published a first set of guidelines to help prepare for obligations coming from the new EU legislation on medical devices. The guidelines, formatted as a questi ...

Read more

Falsified medicines: New rules to enhance patients' safety
Falsified medicines are fake medicines that are dispensed as real, authorised, medicines. In reality, falsified medicines may contain inactive molecules, or active ingredients which are of low quality ...

Read more

European Parliament supports the adoption of an Indoor Air Quality Performance Certificate
On March 13th, the European Parliament plenary adopted the motion for a resolution ‘Clean Air for All: A Europe that Protects’, an initiative put forward by seven Members of the European Parliament &n ...

Read more

EPF: EuropeforPatients campaign
The European Patients Forum (EPF), of which EFA is a long-standing member, has launched a campaign ahead of the EU elections called ‘europeforpatients’. EPF and their Members are calling on political  ...

Read more

EFA continues to be the only patient organisation working with European Chemicals Agency
The European Chemicals Agency (ECHA) organised its annual Accredited Stakeholder Workshop on 21 March 2019 in Brussels to mainly discuss ECHA’s Strategic Plan 2019-2023 with official stakeholders, lik ...

Read more

New IMI Project: 3TR
Despite the wide availability of treatments for autoimmune, inflammatory and allergic diseases, the response to therapy and the disease progression is unpredictable and varies from patient to patient. ...

Read more

New COPD development prediction: the ALEC Project
Although COPD has long been viewed as a predominantly smoking-related disease, there is increasing awareness that lifestyle and the environment contribute to the development of the disease already fro ...

Read more

Our takeaways from the ERS Satellite on COPD
FA took part in the last Satellite Precision Medicine training, organised by the European Respiratory Society (ERS) to deliver free cutting-edge education using live-streaming technology. This one day ...

Read more

European Commission Manual for patients: Patients’ rights to accessing healthcare
The European Commission Directorate General for Health and Food Safety (DG SANTE) has published a manual for patients regarding their rights to access healthcare in any EU/EEA country different from t ...

Read more

Rare diseases: A new platform to support better diagnosis and treatment
In light of the Rare Disease Day in February, the European Commission has launched a new online knowledge-sharing platform to support better diagnosis and treatment for more than 30 million Europeans  ...

Read more

European Food Safety Authority discusses civil society concerns
The use and presence of pesticides, and their classification as endocrine disruptors where among the top food-related health concerns that civil society representatives discussed with European Safety  ...

Read more

EU digital prescriptions system kicks off in Finland and Estonia
We welcome the initiative giving patients the possibility to use digital prescriptions: prescriptions issued by a doctor at home can be issued when going to a pharmacist in another EU member state.  ...

Read more